Your browser doesn't support javascript.
loading
Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.
Saunders, Charlie N; Cornish, Alex J; Kinnersley, Ben; Law, Philip J; Claus, Elizabeth B; Il'yasova, Dora; Schildkraut, Joellen; Barnholtz-Sloan, Jill S; Olson, Sara H; Bernstein, Jonine L; Lai, Rose K; Chanock, Stephen; Rajaraman, Preetha; Johansen, Christoffer; Jenkins, Robert B; Melin, Beatrice S; Wrensch, Margaret R; Sanson, Marc; Bondy, Melissa L; Houlston, Richard S.
Afiliação
  • Saunders CN; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Cornish AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Kinnersley B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Claus EB; School of Public Health, Yale University, New Haven, Connecticut, USA.
  • Il'yasova D; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Schildkraut J; Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA.
  • Barnholtz-Sloan JS; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Olson SH; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Bernstein JL; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Lai RK; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Chanock S; Department of Population and Quantitative Health Sciences and the Cleveland Center for Health Outcomes Research, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Rajaraman P; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Johansen C; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Jenkins RB; Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Melin BS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Wrensch MR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Sanson M; Danish Cancer Society Research Center, Survivorship, Danish Cancer Society, Copenhagen, Denmark.
  • Bondy ML; Oncology Clinic, Finsen Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Houlston RS; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA.
Neuro Oncol ; 22(2): 207-215, 2020 02 20.
Article em En | MEDLINE | ID: mdl-31665421
ABSTRACT

BACKGROUND:

The etiological basis of glioma is poorly understood. We have used genetic markers in a Mendelian randomization (MR) framework to examine if lifestyle, cardiometabolic, and inflammatory factors influence the risk of glioma. This methodology reduces bias from confounding and is not affected by reverse causation.

METHODS:

We identified genetic instruments for 37 potentially modifiable risk factors and evaluated their association with glioma risk using data from a genome-wide association study of 12 488 glioma patients and 18 169 controls. We used the estimated odds ratio of glioma associated with each of the genetically defined traits to infer evidence for a causal relationship with the following exposuresLifestyle and dietary factors-height, plasma insulin-like growth factor 1, blood carnitine, blood methionine, blood selenium, blood zinc, circulating adiponectin, circulating carotenoids, iron status, serum calcium, vitamins (A1, B12, B6, E, and 25-hydroxyvitamin D), fatty acid levels (monounsaturated, omega-3, and omega-6) and circulating fetuin-A;Cardiometabolic factors-birth weight, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, total triglycerides, basal metabolic rate, body fat percentage, body mass index, fasting glucose, fasting proinsulin, glycated hemoglobin levels, diastolic and systolic blood pressure, waist circumference, waist-to-hip ratio; andInflammatory factors- C-reactive protein, plasma interleukin-6 receptor subunit alpha and serum immunoglobulin E.

RESULTS:

After correction for the testing of multiple potential risk factors and excluding associations driven by one single nucleotide polymorphism, no significant association with glioma risk was observed (ie, PCorrected > 0.05).

CONCLUSIONS:

This study did not provide evidence supporting any of the 37 factors examined as having a significant influence on glioma risk.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido